These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 16080809

  • 1. [The control rate of irbesartan/hydrochlorothiazide combination regimen in the treatment of Chinese patients with mild to moderate hypertension].
    Sun NL, Jing S, Chen J.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jul; 33(7):618-21. PubMed ID: 16080809
    [Abstract] [Full Text] [Related]

  • 2. Antihypertensive efficacy and tolerability of irbesartan/hydrochlorothiazide in hypertensive patients stratified by body mass index and type 2 diabetes mellitus status: a post hoc subgroup analysis of the Irbesartan/HCTZ Blood Pressure Reductions in Diverse Patient Populations trial.
    Lewin AJ, Weir MR.
    Clin Ther; 2008 Dec; 30(12):2354-65. PubMed ID: 19167594
    [Abstract] [Full Text] [Related]

  • 3. Irbesartan/hydrochlorothiazide for the treatment of isolated systolic hypertension: a subgroup analysis of the INCLUSIVE trial.
    Chrysant SG, Neutel JM, Ferdinand KC, INCLUSIVE investigators.
    J Natl Med Assoc; 2009 Apr; 101(4):300-7. PubMed ID: 19397219
    [Abstract] [Full Text] [Related]

  • 4. Matrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertension.
    Kochar M, Guthrie R, Triscari J, Kassler-Taub K, Reeves RA.
    Am J Hypertens; 1999 Aug; 12(8 Pt 1):797-805. PubMed ID: 10480473
    [Abstract] [Full Text] [Related]

  • 5. The effects of irbesartan added to hydrochlorothiazide for the treatment of hypertension in patients non-responsive to hydrochlorothiazide alone.
    Rosenstock J, Rossi L, Lin CS, MacNeil D, Osbakken M.
    J Clin Pharm Ther; 1998 Dec; 23(6):433-40. PubMed ID: 10048504
    [Abstract] [Full Text] [Related]

  • 6. The long-term antihypertensive activity and tolerability of irbesartan with hydrochlorothiazide.
    Raskin P, Guthrie R, Flack J, Reeves R, Saini R.
    J Hum Hypertens; 1999 Oct; 13(10):683-7. PubMed ID: 10516738
    [Abstract] [Full Text] [Related]

  • 7. A comparison of the efficacy and safety of irbesartan/HCTZ combination therapy with irbesartan and HCTZ monotherapy in the treatment of moderate hypertension.
    Neutel JM, Franklin SS, Lapuerta P, Bhaumik A, Ptaszynska A.
    J Hum Hypertens; 2008 Apr; 22(4):266-74. PubMed ID: 17928878
    [Abstract] [Full Text] [Related]

  • 8. A home blood pressure monitoring study comparing the antihypertensive efficacy of two angiotensin II receptor antagonist fixed combinations.
    Bobrie G, Delonca J, Moulin C, Giacomino A, Postel-Vinay N, Asmar R, COmparative Study of Efficacy of Irbesartan/HCTZ with Valsartan/HCTZ Using Home Blood Pressure Monitoring in the TreAtment of Mild-to-Moderate Hypertension (COSIMA) Investigators.
    Am J Hypertens; 2005 Nov; 18(11):1482-8. PubMed ID: 16280286
    [Abstract] [Full Text] [Related]

  • 9. A comparison of the efficacy and safety of irbesartan/hydrochlorothiazide combination therapy with irbesartan monotherapy in the treatment of moderate or severe hypertension in diabetic and obese hypertensive patients: a post-hoc analysis review.
    Neutel JM.
    Postgrad Med; 2011 Jul; 123(4):126-34. PubMed ID: 21680997
    [Abstract] [Full Text] [Related]

  • 10. Antihypertensive efficacy of Irbesartan/HCTZ in men and women with the metabolic syndrome and type 2 diabetes.
    Sowers JR, Neutel JM, Saunders E, Bakris GL, Cushman WC, Ferdinand KC, Ofili EO, Weber MA, INCLUSIVE Investigators.
    J Clin Hypertens (Greenwich); 2006 Jul; 8(7):470-80. PubMed ID: 16849900
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in older vs younger patients with hypertension uncontrolled with monotherapy.
    Cushman WC, Neutel JM, Saunders E, Bakris GL, Ferdinand KC, Ofili EO, Sowers JR, Madder R, Weber MA.
    Am J Geriatr Cardiol; 2008 Jul; 17(1):27-36. PubMed ID: 18174757
    [Abstract] [Full Text] [Related]

  • 12. Direct Renin inhibition with aliskiren in obese patients with arterial hypertension.
    Jordan J, Engeli S, Boye SW, Le Breton S, Keefe DL.
    Hypertension; 2007 May; 49(5):1047-55. PubMed ID: 17353513
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of a fixed combination of irbesartan/hydrochlorothiazide in Chinese patients with moderate to severe hypertension.
    Huang QF, Sheng CS, Li Y, Ma GS, Dai QY, Wang JG, INCENT Investigators.
    Drugs R D; 2013 Jun; 13(2):109-17. PubMed ID: 23605903
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of losartan versus enalapril alone or in combination with hydrochlorothiazide in patients with essential hypertension.
    Townsend R, Haggert B, Liss C, Edelman JM.
    Clin Ther; 1995 Jun; 17(5):911-23. PubMed ID: 8595643
    [Abstract] [Full Text] [Related]

  • 15. Combination therapy with candesartan cilexetil 32 mg and hydrochlorothiazide 25 mg provides the full additive antihypertensive effect of the components: A randomized, double-blind, parallel-group study in primary care.
    Edes I, Multicentre Study Group.
    Clin Drug Investig; 2009 Jun; 29(5):293-304. PubMed ID: 19366271
    [Abstract] [Full Text] [Related]

  • 16. Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertension.
    Oparil S, Barr E, Elkins M, Liss C, Vrecenak A, Edelman J.
    Clin Ther; 1996 Jun; 18(4):608-25. PubMed ID: 8879890
    [Abstract] [Full Text] [Related]

  • 17. Initial combination therapy with irbesartan/hydrochlorothiazide for hypertension: an analysis of the relationship between baseline blood pressure and the need for combination therapy.
    Franklin S, Lapuerta P, Cox D, Donovan M.
    J Clin Hypertens (Greenwich); 2007 Dec; 9(12 Suppl 5):15-22. PubMed ID: 18046108
    [Abstract] [Full Text] [Related]

  • 18. Once-daily fixed-combination irbesartan 300 mg/ hydrochlorothiazide 25 mg and circadian blood pressure profile in patients with essential hypertension.
    Coca A, Calvo C, Sobrino J, Gómez E, López-Paz JE, Sierra C, Bragulat E, de la Sierra A.
    Clin Ther; 2003 Nov; 25(11):2849-64. PubMed ID: 14693309
    [Abstract] [Full Text] [Related]

  • 19. Fixed combination of irbesartan and hydrochlorothiazide in the management of hypertension.
    Bramlage P.
    Vasc Health Risk Manag; 2009 Nov; 5(1):213-24. PubMed ID: 19436667
    [Abstract] [Full Text] [Related]

  • 20. Ambulatory blood pressure comparison of the anti-hypertensive efficacy of fixed combinations of irbesartan/hydrochlorothiazide and losartan/hydrochlorothiazide in patients with mild-to-moderate hypertension.
    Neutel JM, Smith D.
    J Int Med Res; 2005 Nov; 33(6):620-31. PubMed ID: 16372579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.